MIMEDX GROUP INC (MDXG) Forecast, Price Target & Analyst Ratings

NASDAQ:MDXG • US6024961012

4.805 USD
+0.04 (+0.95%)
Last: Mar 4, 2026, 12:55 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MIMEDX GROUP INC (MDXG).

Forecast Snapshot

Consensus Price Target

Price Target
$9.86
+ 105.20% Upside

Next Earnings Forecast

Earnings Estimate
Release DateApr 28, 2026
PeriodQ1 / 2026
EPS Estimate-$0.02
Revenue Estimate70.856M

ChartMill Buy Consensus

Rating
81.67%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$9.86
Upside
+ 105.20%
From current price of $4.81 to mean target of $9.86, Based on 12 analyst forecasts
Low
$8.08
Median
$10.20
High
$10.50

Price Target Revisions

1 Month
-20.76%
3 Months
-20.76%

Price Target Summary

12 analysts have analysed MDXG and the average price target is 9.86 USD. This implies a price increase of 105.2% is expected in the next year compared to the current price of 4.805.
The average price target has been revised downward by 20.76% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MDXG Current Analyst RatingMDXG Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

MDXG Historical Analyst RatingsMDXG Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
81.67%
MDXG was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MDXG.
In the previous month the buy percentage consensus was at a similar level.
MDXG was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-23CitizensInitiate Market Outperform
2026-02-17Cantor FitzgeraldMaintains Overweight -> Overweight
2026-01-20Lake StreetMaintains Buy -> Buy
2025-12-17MizuhoMaintains Outperform -> Outperform
2025-07-31Cantor FitzgeraldMaintains Overweight -> Overweight
2025-07-15Cantor FitzgeraldReiterate Overweight -> Overweight
2025-02-27Cantor FitzgeraldReiterate Overweight -> Overweight
2024-08-01Cantor FitzgeraldReiterate Overweight -> Overweight
2024-08-01Craig-HallumMaintains Buy -> Buy
2024-07-02Cantor FitzgeraldInitiate Overweight
2024-05-01HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-07Lake StreetInitiate Buy
2024-03-01MizuhoMaintains Buy -> Buy
2023-10-31MizuhoMaintains Buy -> Buy
2023-10-27Craig-HallumInitiate Buy
2023-08-02MizuhoMaintains Buy -> Buy
2023-08-02HC Wainwright & Co.Maintains Buy -> Buy
2023-06-21HC Wainwright & Co.Maintains Buy -> Buy
2023-05-03HC Wainwright & Co.Maintains Buy
2023-03-02HC Wainwright & Co.Reiterate Buy
2022-10-13MizuhoInitiate Buy
2022-09-07HC Wainwright & Co.Maintains Buy
2021-09-14HC Wainwright & Co.Maintains Buy
2021-07-26Northland Capital MarketsInitiate Outperform
2021-03-19HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release DateApr 28, 2026
PeriodQ1 / 2026
EPS Estimate-$0.02
Revenue Estimate70.856M
Revenue Q2Q-19.67%
EPS Q2Q-131.16%
Number of Analysts8

Next Earnings Revisions

Revenue (1 Month)
-0.15%
Revenue (3 Months)
-0.15%
EPS (1 Month)
-1.13%
EPS (3 Months)
-30.95%

Next Earnings Summary

MDXG is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is -0.02 USD and the consensus revenue estimate is 70.86M USD.
The next earnings revenue estimate has been revised downward by 0.15% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
MDXG revenue by date.MDXG revenue by date.
321.477M
20.04%
348.879M
8.52%
418.63M
19.99%
354.36M
-15.35%
400.94M
13.14%
442.22M
10.30%
470.63M
6.42%
528.16M
12.22%
EBITDA
YoY % growth
MDXG ebitda by date.MDXG ebitda by date.
45.719M
622.50%
56.654M
23.92%
78.768M
39.03%
57.477M
-27.03%
77.724M
35.23%
103.89M
33.67%
106.18M
2.20%
124.64M
17.39%
EBIT
YoY % growth
MDXG ebit by date.MDXG ebit by date.
42.292M
430.41%
50.613M
19.68%
63.887M
26.23%
22.734M
-64.42%
48.284M
112.39%
116.38M
141.03%
72.012M
-38.12%
89.25M
23.94%
Operating Margin
MDXG operating margin by date.MDXG operating margin by date.
13.16%14.51%15.26%6.42%12.04%26.32%15.30%16.90%
EPS
YoY % growth
MDXG eps by date.MDXG eps by date.
0.32
196.97%
0.29
-9.37%
0.41
41.38%
0.12
-71.81%
0.24
105.89%
0.33
37.14%
0.37
12.50%
0.45
22.22%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.02
-131.16%
0.01
-86.40%
0.10
-32.00%
0.11
12.20%
0.06
427.33%
0.10
650.19%
0.13
30.00%
0.16
45.45%
Revenue
Q2Q % growth
70.856M
-19.67%
82.016M
-16.82%
113.15M
-0.51%
119.85M
1.49%
94.35M
33.16%
107.2M
30.71%
116.99M
3.39%
128.42M
7.15%
EBITDA
Q2Q % growth
6.885M
-39.89%
12.674M
-32.37%
28.662M
-15.33%
29.988M
-16.60%
12.546M
82.22%
22.338M
76.25%
26.928M
-6.05%
34.068M
13.61%
EBIT
Q2Q % growth
-2.882M
-134.92%
2.591M
-79.05%
16.422M
-25.99%
20.349M
-3.45%
7.956M
376.11%
17.748M
584.99%
22.338M
36.02%
29.478M
44.86%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MDXG Yearly Revenue VS EstimatesMDXG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
MDXG Yearly EPS VS EstimatesMDXG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-7.32%
EPS Next 5 Year
1.82%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
2.10%
Revenue Next 5 Year
4.92%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
15.13%
EBIT Next 5 Year
12.86%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MIMEDX GROUP INC / MDXG Forecast FAQ

What do analysts expect the price target to be for MIMEDX GROUP INC (MDXG)?

12 analysts have analysed MDXG and the average price target is 9.86 USD. This implies a price increase of 105.2% is expected in the next year compared to the current price of 4.805.


Can you provide the upcoming earnings date for MIMEDX GROUP INC?

MIMEDX GROUP INC (MDXG) will report earnings on 2026-04-28.


What are the consensus estimates for MDXG stock next earnings?

The consensus EPS estimate for the next earnings of MIMEDX GROUP INC (MDXG) is -0.02 USD and the consensus revenue estimate is 70.86M USD.


What is the expected long term growth rate for MDXG stock?

The expected long term growth rate for MIMEDX GROUP INC (MDXG) is 2.1%.